Compare Amylx Pharmaceuticals Inc (AMLX) vs GE Vernova Inc (GEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs GE Vernova Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while GE Vernova Inc trades at $1,028.45 (market cap $269.50B). The key difference: GE Vernova Inc is far larger — about 102.1× Amylx Pharmaceuticals Inc's market cap, and GE Vernova Inc pays a 0.2% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | GEV | |
|---|---|---|
Market Cap | $2.64B | $269.50B |
Sector | Health | Technology |
52-Week High | $24.19 | $1.17K |
52-Week Low | $7.82 | $547.96 |
Enterprise Value | $2.39B | $259.17B |
Dividend Yield | — | 0.2% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About GE Vernova Inc
GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →
